← Leaderboards
James Campbell Cusack
University Of North Carolina Chapel Hill
$2,265,526
Attributed
$2,265,526
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $358.8K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,265,526 · 3
By mechanism
R01$1,729,556 · 1
K08$535,970 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Albert Sidney Baldwin$25,224,800
- Bruce F Israel$410,520
- David W Ollila$95,068
- Gary M Pollack$1,883,076
- Wenbin Lin$10,248,495
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisAthymic MouseNeoplasm /Cancer ChemotherapyTissue /Cell CultureNeoplasm /Cancer TransplantationGenetic TranscriptionGenetic TranslationNuclear Factor Kappa BetaProtein Kinase CPhosphorylationIrinotecanDrug InteractionsAntioxidantsCd95 MoleculeFree Radical OxygenCancer TherapyCancer PatientCancer DiagnosisApoptoticAdvanced Malignant NeoplasmCancer Cell LineChemotherapy-Oncologic ProcedureClinical ResearchCancer Cell
Grant awards (13)
The Role of NF-kappaB in Chemotherapy Resistance$340,162
R01 · FY2009 · CA · contact PI
The Role of NF-kappaB in Chemotherapy Resistance$340,162
R01 · FY2008 · CA · contact PI
The Role of NF-kappaB in Chemotherapy Resistance$340,162
R01 · FY2007 · CA · contact PI
The Role of NF-kappaB in Chemotherapy Resistance$350,320
R01 · FY2006 · CA · contact PI
The Role of NF-kappaB in Chemotherapy Resistance$358,750
R01 · FY2005 · CA
NFKB IN INHIBITION OF CHEMOTHERAPY INDUCED APOPTOSIS$135,352
K08 · FY2004 · CA
NFKB IN INHIBITION OF CHEMOTHERAPY INDUCED APOPTOSIS$135,352
K08 · FY2003 · CA
NFKB IN INHIBITION OF CHEMOTHERAPY INDUCED APOPTOSIS$135,352
K08 · FY2002 · CA
NFKB IN INHIBITION OF CHEMOTHERAPY INDUCED APOPTOSIS$110,268
K08 · FY2000 · CA
NFKB IN INHIBITION OF CHEMOTHERAPY INDUCED APOPTOSIS$19,646
K08 · FY2000 · CA
ACTIVE IMMUNOTHERAPY W/ BCG &MELANOMA VACCINE, CANCERVA$0
M01 · FY2000 · RR
ACTIVE IMMUNOTHERAPY W/ BCG &MELANOMA VACCINE, CANCERVA$0
M01 · FY2000 · RR
ACTIVE IMMUNOTHERAPY W/ BCG &MELANOMA VACCINE, CANCERVA$0
M01 · FY2000 · RR